Activation level as a mediator between behavioral activation, sex, and depression among treatment-seeking smokers.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
03 2021
Historique:
received: 02 06 2020
revised: 08 10 2020
accepted: 13 10 2020
pubmed: 3 11 2020
medline: 15 5 2021
entrez: 2 11 2020
Statut: ppublish

Résumé

Behavioral activation (BA) has gained interest when combined with tobacco interventions as it relates to improved depression and cessation rates. However, no prior efforts have examined mediators of BA effectiveness and sex-dependent effects. This secondary analysis assesses the main and interactive effects of sex and type of smoking cessation intervention [a cognitive behavioral treatment (CBT) only, or CBT + BA] on depressive symptoms among treatment-seeking patients with depression. It also examines the activation level as a mediator between BA, BA by sex, and depression. 120 smokers were assigned to an 8-week CBT or to CBT + BA. They completed the Beck Depression Inventory-II (BDI-II) and the Behavioral Activation for Depression scale-short-form (BADS-SF). A two-way ANOVA assessed the effects of sex and treatment condition on participants' BDI-II scores. A moderated mediational analysis tested whether the indirect effect of treatment condition on BDI-II through BADS-SF differed by sex. After controlling for end-of-treatment smoking status and baseline BDI-II, there were no significant effects of treatment condition, sex, and their interaction on end-of-treatment BDI-II. Being a male was indirectly associated with higher BDI-II scores through lower BADS-SF score (point estimate = -3.440; SE = 1.637; BC 95% CI [-7.105, -0.749]). This effect was not found for women. There is a need to tailor interventions by sex when treating smokers with depression. It is recommended to assess symptoms such as mental rumination or self-consciousness, which tend to be more pronounced in women.

Identifiants

pubmed: 33131968
pii: S0306-4603(20)30845-5
doi: 10.1016/j.addbeh.2020.106715
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106715

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Sara Weidberg (S)

Department of Psychology, University of Oviedo, Plaza Feijóo s/n, 33003 Oviedo, Spain. Electronic address: weidbergsara.uo@uniovi.es.

Alba González-Roz (A)

Department of Psychology, University of Oviedo, Plaza Feijóo s/n, 33003 Oviedo, Spain.

Gloria García-Fernández (G)

Department of Psychology, University of Oviedo, Plaza Feijóo s/n, 33003 Oviedo, Spain.

Roberto Secades-Villa (R)

Department of Psychology, University of Oviedo, Plaza Feijóo s/n, 33003 Oviedo, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH